iLoF
Mehak Mumtaz is a strategy consultant and the Co-Founder & COO of iLoF. Mehak has a wealth of experience in the corporate and startup worlds.
Mehak started their career at Procter & Gamble as part of the R&D European PhD Seminar. Mehak was then a visiting tutor for Access to Health Sciences at Ruskin College. In 2018, they took part in the BioEntrepreneur Bootcamp, an eight-week interactive program with on-site and off-site sessions in Munich, France (Medicen), Netherlands (Yes!Delft), and London (Imperial Innovations).
In 2019, they joined EY-Parthenon as a strategy consultant. During their time there, they worked with clients across a range of industries on projects such as growth strategy, M&A, and organisational design. In 2020, they co-founded iLoF, a startup that helps companies to identify and assess opportunities for innovation and growth.
Mehak Mumtaz has a DPhil in Pathology from the University of Oxford, where their focus was on Oncology and Cancer Biology. Mehak also has an MBiochem from the University of Oxford in Biochemistry. In 2018, they completed the Idea to Impact 2018 Strategy & Innovation Module with EMBA from Saïd Business School, University of Oxford. Additionally, they have a Masters Project in Biochemistry and Molecular Biology from Princeton University.
Some of their coworkers include and Paula Sampaio - Co-Founder & CSO. Mehak Mumtaz reports to Luís Valente, Co-Founder & CEO.
This person is not in any offices
iLoF
1 followers
iLoF is enabling a new era of personalized, precision medicine, by providing screening and stratification tools in an affordable, fast, portable way. It is currently focusing a patented platform technology on the epidemic of our century: Alzheimer's disease.